Artificial intelligence for secondary prevention of myocardial infarction: A qualitative study of patient and health professional perspectives

被引:8
作者
Pelly, Melissa [1 ,2 ]
Fatehi, Farhad [1 ,2 ]
Liew, Danny [3 ,4 ]
Verdejo-Garcia, Antonio [1 ,2 ,5 ]
机构
[1] Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia
[2] Monash Univ, Turner Inst Brain & Mental Hlth, Clayton, Vic 3800, Australia
[3] Monash Univ, Sch Publ Hlth & Prevent Med, Clayton, Vic 3800, Australia
[4] Alfred Hosp, 55 Commercial Rd, Melbourne, Vic 3800, Australia
[5] Monash Univ, Room 536,18 Innovat Walk, Clayton, Vic 3800, Australia
关键词
Artificial intelligence; Secondary prevention; Myocardial infarction; Co-design; Perspectives; Qualitative study; FOCUS; CHALLENGES; INTERVIEWS;
D O I
10.1016/j.ijmedinf.2023.105041
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Background: Artificial intelligence (AI) has potential to improve self-management of several chronic conditions. However, the perspective of patients and healthcare professionals regarding AI-enabled health management programs, which are key to successful implementation, remains poorly understoodPurpose: To explore the opinions of people with a history of myocardial infarction (PHMI) and health pro-fessionals on the use of AI for secondary prevention of MI. Procedure: Three rounds of focus groups were conducted via videoconferencing with 38 participants: 22 PHMI and 16 health professionals.Findings: We identified 21 concepts stemming from participants' views, which we classified into five categories: Trust; Expected Functions; Adoption; Concerns; and Perceived Benefits. Trust covered the credibility of infor-mation and safety to believe health advice. Expected Functions covered tailored feedback and personalised advice. Adoption included usability features and overall interest in AI. Concerns originated from previous negative experience with AI. Perceived Benefits included the usefulness of AI to provide advice when regular contact with healthcare services is not feasible. Health professionals were more optimistic than PHMI about the usefulness of AI for improving health behaviour.Conclusions: Altogether, our findings provide key insights from end-users to improve the likelihood of successful implementation and adoption of AI-enabled systems in the context of MI, as an exemplar of broader applications in chronic disease management.
引用
收藏
页数:8
相关论文
共 44 条
  • [1] Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
    Adadi, Amina
    Berrada, Mohammed
    [J]. IEEE ACCESS, 2018, 6 : 52138 - 52160
  • [2] Improving cardiac rehabilitation patient adherence via personalized interventions
    Aharon, Keren B.
    Gershfeld-Litvin, Avital
    Amir, On
    Nabutovsky, Irene
    Klempfner, Robert
    [J]. PLOS ONE, 2022, 17 (08):
  • [3] [Anonymous], Digital health
  • [4] The promise of artificial intelligence: a review of the opportunities and challenges of artificial intelligence in healthcare
    Aung, Yuri Y. M.
    Wong, David C. S.
    Ting, Daniel S. W.
    [J]. BRITISH MEDICAL BULLETIN, 2021, 139 (01) : 4 - 15
  • [5] Global burden of CVD: focus on secondary prevention of cardiovascular disease
    Bansilal, Sameer
    Castellano, Jose M.
    Fuster, Valentin
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 201 : S1 - S7
  • [6] Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
    Barredo Arrieta, Alejandro
    Diaz-Rodriguez, Natalia
    Del Ser, Javier
    Bennetot, Adrien
    Tabik, Siham
    Barbado, Alberto
    Garcia, Salvador
    Gil-Lopez, Sergio
    Molina, Daniel
    Benjamins, Richard
    Chatila, Raja
    Herrera, Francisco
    [J]. INFORMATION FUSION, 2020, 58 : 82 - 115
  • [7] 'Just like a normal pain', what do people with diabetes mellitus experience when having a myocardial infarction: a qualitative study recruited from UK hospitals
    Berman, Nikita
    Jones, Melvyn Mark
    De Coster, Daan A.
    [J]. BMJ OPEN, 2017, 7 (09):
  • [8] Bohr A., 2020, Artificial Intelligence in Healthcare, V2020, P25, DOI [10.1016/B978-0-12-818438-7.00002-2, DOI 10.1016/B978-0-12-818438-7.00002-2]
  • [9] Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [https://doi.org/10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]
  • [10] Brundisini F, 2013, Ont Health Technol Assess Ser, V13, P1